Release of 92-kd type IV collagenase/gelatinase, also known as gelatin
ase B, by inflammatory and tumor cells is increasingly recognized and
is believed to facilitate cellular migration across basement membranes
. It has been implicated in the pathogenesis of many diseases, but lit
tle is known of its cellular origin(s) and function in liver. In this
study we have demonstrated synthesis and release of gelatinase B by hu
man and rat Kupffer cells in primary culture. Northern analysis of RNA
extracted from Kupffer cells stimulated with phorbol ester demonstrat
ed a 2.8 kb transcript for gelatinase B. Immunoblotting and zymography
of serum-free Kupffer cell-conditioned media demonstrated extracellul
ar release of immunoreactive enzyme and gelatinase activity, Mr 92,000
(95,000 from rat cells). The organomercurial 4-aminophenyl mercuric a
cetate (APMA) activated the enzyme in vitro, indicating secretion prim
arily as a proenzyme. Stimulation of Kupffer cells by phorbol ester ma
rkedly induced gelatinase B release, which was inhibited by cyclohexim
ide. In contrast, cycloheximide had no effect on constitutive secretio
n in culture, suggesting that there is some intracellular storage. Kup
ffer cell-derived gelatinase B was also partially purified and charact
erized. After separation by gelatin sepharose and gel filtration chrom
atography, gelatin-degrading activities of 95, 88, 75, and 65 kd were
detected, the three lower-molecular-weight species probably representi
ng activated forms. Enzyme activity was inhibited by ethylenediaminete
tra-acetic acid (EDTA), but not by serine- and thiol-protease inhibito
rs, and was restored by zinc. Activity was also inhibited by tissue in
hibitor of metalloproteinase-1 (TIMP-1) and alpha-2 macroglobulin. The
partially purified enzyme rapidly degraded denatured collagens (gelat
in) as well as native types III, IV, and V collagens, but had no activ
ity against casein, types I and VI collagens.